Medical Cannabis Co. Yom Chai Forms Partnership With Israeli R&D Company Kaneh-B to Conduct Scientific Clinical Trials on ADHD

This information was provided by kamgs.com

Send your Press Release here.

New Israeli Medical Cannabis Company, Yom Chai Forms Strategic Partnership With Israeli Research and Development Company Kaneh-B to Conduct Scientific Clinical Trials on ADHD and to Distribute Approved European Dermal Products to Market 

Tel Aviv, Israel, Oct 4, 2018…Yom Chai is pleased to announce that it has entered into a strategic partnership with Kaneh-B to co-found the development and clinical validation of a range of cannabis based ADHD products.

Yom Chai’s objective is to conduct scientific trials in Israel utilizing various Cannabinoid and Terpene profiles with the goal of realizing multiple successful discoveries (outcomes). Yom Chai’s goal is to bridge the gap between patients and doctors to bring scientifically validated products to market.

Scot Albert, COO of Yom Chai said, “We are excited to be working with Ofer Segal CEO and Yahav Blaicher Co-Founder of Kaneh-B to formulate, manufacture, and distribute world class Cannabis based products to the international marketplace”.

Emerald contributor since March 2012

Comments

Your email address will not be published.